Nektar Therapeutics (NKTR) Ownership - Who Owns Nektar Therapeutics?
Nektar Therapeutics (NKTR) Ownership Overview
- 0.46% Insiders
- 19.38% Mutual Funds
- 10.34% Other Institutional Investors
- 14.18% ETFs
- 55.64% Public Companies and Individual Investors
The ownership structure of Nektar Therapeutics (MX:NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 43.91% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 55.64% is owned by Public Companies and Individual Investors.
The ownership structure of Nektar Therapeutics (MX:NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 29.73% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 14.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2026 | Howard Robin | $30,088 | |
| Aug 19, 2026 | Jonathan Zalevsky | $13,388 | |
| May 20, 2026 | Howard Robin | $29,086 | |
| May 20, 2026 | Jonathan Zalevsky | $13,036 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 2,775,383 | Institution | 8.13% | 149,212,916 |
| Vanguard | 1,798,480 | Institution | 5.27% | 96,691,680 |
| Vanguard Index Funds | 1,462,679 | Institution | 4.28% | 78,638,011 |
| Ishares | 1,311,233 | Institution | 3.84% | 70,495,820 |
| Spdr | 1,158,453 | Institution | 3.39% | 62,281,909 |
| Travis Knapp Anderson | 600,873 | Institution | 1.76% | 32,304,735 |
| Michael Rockefeller | 470,875 | Institution | 1.38% | 25,315,653 |
| Fidelity Salem Street Trust | 415,968 | Institution | 1.22% | 22,363,688 |
| Fidelity Concord Street Trust | 333,696 | Institution | 0.98% | 17,940,498 |
| Delaware Group Equity Funds Iv | 290,569 | Institution | 0.85% | 15,621,861 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 2,775,383 | Institution | 8.13% | 149,212,916 |
| Vanguard Index Funds | 1,462,679 | Institution | 4.28% | 78,638,011 |
| Fidelity Salem Street Trust | 415,968 | Institution | 1.22% | 22,363,688 |
| Fidelity Concord Street Trust | 333,696 | Institution | 0.98% | 17,940,498 |
| Delaware Group Equity Funds Iv | 290,569 | Institution | 0.85% | 15,621,861 |
| Primecap Odyssey Funds | 240,034 | Institution | 0.70% | 12,904,948 |
| Vanguard Scottsdale Funds | 237,390 | Institution | 0.70% | 12,762,799 |
| Schwab Capital Trust | 107,101 | Institution | 0.31% | 5,758,071 |
| Financial Investors Trust | 104,721 | Institution | 0.31% | 5,630,115 |
| Blackrock Funds | 99,150 | Institution | 0.29% | 5,330,601 |
FAQ
Who Owns Nektar Therapeutics (MX:NKTR)?
According to the latest TipRanks data, approximately 10.34% of the company's stock is held by institutional investors, 0.46% is held by insiders, and 55.64% is held by retail investors.
What percentage of Nektar Therapeutics (MX:NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.34% of Nektar Therapeutics (MX:NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (MX:NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.64% of Nektar Therapeutics (MX:NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (MX:NKTR)?
Fidelity Mt. Vernon Street Trust owns the most shares of Nektar Therapeutics (MX:NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.